
About Sheel Biotech
Sheel Biotech is a publicly listed company based in Delhi (India) founded in 1991. Biotechnology, floriculture, greenhouse solutions, and agricultural services in India. It operates in the Industrial Goods & Manufacturing and Agriculture sectors. The company has 53 employees. Its website sheelbiotech.com draws about 11 thousand monthly visits. Its Indian entity Sheel Biotech Limited reported revenue of βΉ111 Cr. Sheel Biotech offers products and services including Planting Material and Hortiprojects. Its focus areas include Food and Agriculture, Industrial Supplies, Greenhouse Manufacturing and Greenhouse Solutions.
Company details
Sheel Biotech Limited is incorporated as a certified company in the fields of biotechnology, floriculture, and greenhouse solutions, with ISO standards being maintained and a research lab recognized by government departments. Services such as tissue culture for planting materials, turnkey projects, organic adoption, and skill development for farmers are offered through expert management. International presence is established in regions like the UK and Middle East, supporting sustainable farming practices. Operations are based in New Delhi with regional offices across India, focusing on eco-friendly and innovative agricultural advancements.
- Market Cap₹122 Cr
SHEEL-SM · NSE
- Share Price₹58.95
-1.83% today
- Revenue₹110 Cr
FY 2025-26 · +8.1% YoY
- EBITDA₹16.28 Cr
Margin 14.8%
- Net Profit₹11.79 Cr
FY 2025-26 · +13.3% YoY
- P/E (TTM)10.4x
P/B 1.0x
- ROE11.2%
ROCE 13.4%
- Debt / Equity0.12
Interest cover 12.6x
- Employee Count53
Associated legal entities of Sheel Biotech
Sheel Biotech operates through Sheel Biotech Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sheel Biotech Limited Listed CIN U24239DL1991PLC046531 | Active | 26 Nov 1991 | New Delhi, Delhi | ₹111 Cr | 53 | 9 | View details |
Products & Services of Sheel Biotech
Sheel Biotech offers a comprehensive portfolio of products and services, including Planting Material and Hortiprojects.
High-quality planting materials are provided through tissue culture and hydroponics for various crops
Turnkey horticulture projects are undertaken with innovative solutions and expert guidance
Apps and channels of Sheel Biotech
its YouTube channel Sheel Biotech Ltd has 1.29K subscribers and 17 videos.
Videos from Sheel Biotech
The most watched videos on Sheel Biotech's YouTube channel, Sheel Biotech Ltd (1.29K subscribers). Click a video to play it here.
More on Sheel Biotech Ltd.
Board of directors of Sheel Biotech Limited (Sheel Biotech)
Sheel Biotech Limited is the primary company behind Sheel Biotech. The board of Sheel Biotech Limited currently have 6 directors; the longest-serving is Sanjay Chandak, appointed in 2011. 14 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjay Chandak DIN 03459807 | Director | 12 Oct 2011 | 15 yrs | Sheel Biotech Limited |
| Ramesh Chandra Srivastava DIN 09497683 | Director | 31 Mar 2023 | 3 yrs 6 mo | Sheel Biotech Limited |
| Divye Chandak DIN 07100902 | Managing Director | 22 Aug 2024 | 2 yrs 2 mo | Sheel Biotech Limited |
| Atul Kumar DIN 10749155 | Director | 28 Aug 2024 | 2 yrs 1 mo | Sheel Biotech Limited |
| Mini Chadha DIN 10742674 | Director | 28 Aug 2024 | 2 yrs 1 mo | Sheel Biotech Limited |
| Shyamsundar Bang DIN 00011327 | Director | 28 Aug 2024 | 2 yrs 1 mo | Sheel Biotech Limited |
IPO & Listings of Sheel Biotech
Sheel Biotech is a publicly listed company on the NSE with ticker symbol SHEEL in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Oct 2025
- Listed onNSE: SHEEL
- Listed entitySheel Biotech Limited
- Exchange sectorProcess industries
- ISININE0YJV01017
- Share price₹60.80 (-0.08% on the day) · 2026-10-14
- Market capitalisation₹120 Cr
- Price to earnings10.5
- EPS (diluted, trailing year)₹5.78
- Volume (last session)2,000
Financials of Sheel Biotech
Exchange-reported figures of Sheel Biotech Limited, the listed company behind Sheel Biotech (NSE: SHEEL-SM).
Financial Highlights
FY 2025-26 Β· StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 110 | 102 | 103 | 88.94 | 84.39 | 63.03 |
| Revenue growth | +8.1% | -1.3% | +15.9% | +5.4% | +33.9% | - |
| EBITDA | 16.28 | 14.97 | 14.44 | 8.83 | 6.36 | 6.52 |
| EBITDA margin | +14.8% | +14.7% | +14.0% | +9.9% | +7.5% | +10.3% |
| Profit before tax | 14.01 | 12.82 | 12.23 | 6.37 | 4.57 | 4.79 |
| Net profit | 11.79 | 10.41 | 10.45 | 5.08 | 4.45 | 4.69 |
| Net profit margin | +10.7% | +10.2% | +10.1% | +5.7% | +5.3% | +7.4% |
| EPS (βΉ) | 5.78 | 7.19 | 25.28 | 12.25 | 10.88 | 11.58 |
| Balance sheet | ||||||
| Total assets | 137 | 102 | 96.61 | 83.00 | 83.58 | 77.98 |
| Net worth | 127 | 83.87 | 72.69 | 63.54 | 59.75 | 56.71 |
| Total debt | 8.98 | 17.36 | 23.54 | 19.17 | 23.58 | 21.20 |
| Cash & bank | 2.18 | 0.46 | 0.60 | 0.21 | 0.31 | 0.46 |
| Net working capital | 119 | 89.60 | 86.05 | 72.01 | 73.85 | 69.65 |
| Cash flow | ||||||
| Cash from operations | (17.57) | 8.51 | (0.92) | 9.29 | 2.19 | - |
| Cash from investing | (6.57) | (2.18) | (0.25) | (2.18) | (2.12) | - |
| Cash from financing | 25.86 | (6.48) | 1.56 | (7.22) | (0.23) | - |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 110 | 102 | 103 | 88.94 | 84.39 | 63.03 |
| Revenue growth | +8.1% | -1.3% | +15.9% | +5.4% | +33.9% | - |
| Other income | 0.71 | 0.52 | 0.26 | 0.08 | 0.33 | 0.22 |
| Total expenses | 93.74 | 86.78 | 88.67 | 80.11 | 78.03 | 56.51 |
| Employee cost | 14.73 | 13.48 | 11.19 | 9.22 | 9.09 | 7.81 |
| EBITDA | 16.28 | 14.97 | 14.44 | 8.83 | 6.36 | 6.52 |
| EBITDA margin | +14.8% | +14.7% | +14.0% | +9.9% | +7.5% | +10.3% |
| Depreciation | 1.07 | 0.90 | 0.99 | 1.02 | 0.94 | 0.76 |
| Interest | 1.91 | 1.77 | 1.48 | 1.52 | 1.18 | 1.19 |
| Profit before tax | 14.01 | 12.82 | 12.23 | 6.37 | 4.57 | 4.79 |
| Tax | 2.26 | 2.06 | 1.78 | 1.29 | 0.09 | 0.00 |
| Net profit | 11.79 | 10.41 | 10.45 | 5.08 | 4.45 | 4.69 |
| Net profit margin | +10.7% | +10.2% | +10.1% | +5.7% | +5.3% | +7.4% |
| EPS (βΉ) | 5.78 | 7.19 | 25.28 | 12.25 | 10.88 | 11.58 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 20.35 | 14.95 | 4.14 | 4.14 | 4.14 | 4.14 |
| Reserves & surplus | 107 | 68.92 | 68.55 | 59.40 | 55.61 | 52.57 |
| Shareholders' funds (net worth) | 127 | 83.87 | 72.69 | 63.54 | 59.75 | 56.71 |
| Secured loans | 8.98 | 13.25 | 13.31 | 10.03 | 12.24 | 11.23 |
| Unsecured loans | 0.00 | 4.11 | 10.23 | 9.14 | 11.34 | 9.97 |
| Total debt | 8.98 | 17.36 | 23.54 | 19.17 | 23.58 | 21.20 |
| Total liabilities | 137 | 102 | 96.61 | 83.00 | 83.58 | 77.98 |
| Assets | ||||||
| Gross block | 23.99 | 21.27 | 20.16 | 19.87 | 18.57 | 7.55 |
| Net block | 9.48 | 7.49 | 7.23 | 7.93 | 7.65 | 7.55 |
| Capital work in progress | 3.45 | 0.00 | 0.00 | 0.00 | 0.14 | 0.00 |
| Investments | 0.79 | 0.79 | 0.80 | 0.80 | 0.80 | 0.01 |
| Inventories | 29.57 | 39.39 | 32.77 | 19.30 | 11.83 | 6.28 |
| Sundry debtors | 61.81 | 55.08 | 57.70 | 56.05 | 64.71 | 60.69 |
| Cash & bank balances | 2.18 | 0.46 | 0.60 | 0.21 | 0.31 | 0.46 |
| Loans & advances | 34.28 | 4.22 | 4.32 | 7.24 | 6.36 | 6.55 |
| Total current assets | 128 | 99.15 | 95.39 | 82.80 | 83.21 | 73.98 |
| Total current liabilities | 9.24 | 9.55 | 9.34 | 10.79 | 9.36 | 4.33 |
| Net working capital | 119 | 89.60 | 86.05 | 72.01 | 73.85 | 69.65 |
| Total assets | 137 | 102 | 96.61 | 83.00 | 83.58 | 77.98 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 0.46 | 0.60 | 0.21 | 0.31 | 0.46 | - |
| Net cash from operating activities | (17.57) | 8.51 | (0.92) | 9.29 | 2.19 | - |
| Net cash from investing activities | (6.57) | (2.18) | (0.25) | (2.18) | (2.12) | - |
| Net cash from financing activities | 25.86 | (6.48) | 1.56 | (7.22) | (0.23) | - |
| Net change in cash | 1.72 | (0.14) | 0.39 | (0.10) | (0.15) | - |
| Closing cash | 2.18 | 0.46 | 0.60 | 0.21 | 0.31 | - |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +8.1% | -1.3% | +15.9% | +5.4% | +33.9% | - |
| EBITDA growth | +8.8% | +3.7% | +63.5% | +38.8% | -2.5% | - |
| PBT growth | +9.3% | +4.8% | +92.0% | +39.4% | -4.6% | +9997.0% |
| Net income growth | +13.3% | -0.4% | +105.7% | +14.2% | -5.1% | - |
| Revenue CAGR (3Y) | +7.4% | +6.4% | +17.8% | - | - | - |
| EBITDA CAGR (3Y) | +22.6% | +33.0% | +30.4% | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +10.7% | +10.6% | +10.1% | +5.7% | +5.3% | +7.6% |
| Return on capital employed | +13.4% | +14.7% | +15.3% | +9.5% | +7.1% | +7.7% |
| Return on net worth | +11.2% | +13.8% | +15.4% | +8.2% | +7.8% | +8.5% |
| Debt / equity | 0.12 | 0.26 | 0.31 | 0.35 | 0.38 | 0.37 |
| Long-term debt / equity | 0.03 | 0.10 | 0.14 | 0.19 | 0.22 | 0.21 |
| Interest cover | 12.56 | 12.58 | 11.00 | 19.46 | 21.77 | 20.66 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 4.86 | 4.91 | 5.15 | 4.63 | 6.46 | 8.35 |
| Inventory turnover | 3.19 | 2.82 | 3.96 | 5.71 | 9.32 | 10.04 |
| Debtors turnover | 1.88 | 1.80 | 1.81 | 1.47 | 1.35 | 1.04 |
| EPS (βΉ) | 5.78 | 7.19 | 25.28 | 12.25 | 10.88 | 11.58 |
| Dividend per share (βΉ) | 0.00 | 1.00 | 3.10 | 3.10 | 3.10 | 0.00 |
| Book value per share (βΉ) | 62.40 | 56.09 | 175.42 | 153.34 | 144.19 | 136.87 |
Web traffic of Sheel Biotech
The website of Sheel Biotech (sheelbiotech.com) receives about 11K visits a month.
- Monthly visits11K
▲ 173.5% vs previous month
Websites whose visitors overlap most with Sheel Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| kanbiosys.com | 100% | 2.4K | #7,124,451 | View details | |
| agricultureinformation.com | 90% | 19.4K | #1,497,211 | View details | |
alexafarms.in | alexafarms.in | 85% | #6,428,531 | β | |
| nevaplantations.com | 85% | #2,908,532 | View details | ||
sbagritech.com | sbagritech.com | 84% | #8,800,315 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 6 similar websites and full traffic analytics for Sheel Biotech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Industrial HVAC Systems
2 companies that operate in the same segment as Sheel Biotech (Industrial HVAC Systems) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Industrial refrigeration systems and related products are manufactured. | 1993 | Ahmedabad, Gujarat, India | USD 71.2 M | 161 | ||
Aluminum and copper fin-and-tube heat exchangers are manufactured. | 2017 | Neemrana, Rajasthan, India | USD 63.95 M | 648 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sheel Biotech
Complete news archive for Sheel Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sheel Biotech
Sheel Biotech was founded in 1991.
Sheel Biotech is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Sheel Biotech has 53 employees.
The primary company behind Sheel Biotech, Sheel Biotech Limited, reported revenue of βΉ111 Cr for FY 2026, up 8% year on year.
Sheel Biotech Limited is incorporated as a certified company in the fields of biotechnology, floriculture, and greenhouse solutions, with ISO standards being maintained and a research lab recognized by government departments. Services such as tissue culture for planting materials, turnkey projects, organic adoption, and skill development for farmers are offered through expert management. International presence is established in regions like the UK and Middle East, supporting sustainable farming practices. Operations are based in New Delhi with regional offices across India, focusing on eco-friendly and innovative agricultural advancements.
Sheel Biotech offers Planting Material and Hortiprojects.
Yes, Sheel Biotech is publicly traded on NSE under the ticker symbol SHEEL.
Sheel Biotech operates through Sheel Biotech Limited.
The legal entities of Sheel Biotech currently have 9 directors, including Divye Chandak, Sanjay Chandak, Ramesh Chandra Srivastava and others.
